Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma

Open access

Abstract

Tumor-infiltrating cytotoxic T lymphocytes (TILs), including CD8 TILs, have been associated with favorable clinical outcomes in multiple tumor types. Tumor-infiltrating CD8 T cells and major histocompatibility complex (MHC) class I expression in urothelial carcinoma (UC) have not been previously reported. Most immune responses are mediated by local cytotoxic lymphocytes (CD8 T cells), which can eradicate tumor cells by recognizing tumor-associated antigens presented by MHC class I molecules. Here we analyzed the presence of intratumoral CD8 T cells, the expression of MHC class I antigen, and the expression of the NY-ESO-1 tumor antigen in UC samples and correlated our findings with clinical outcome. Immunohistochemical staining for intratumoral CD8 T cells in tissue samples from 69 patients with UC showed that patients with advanced UC (pT2, pT3, or pT4) and higher numbers of CD8 TILs within the tumor (> or =8) had better disease-free survival (P < 0.001) and overall survival (P = 0.018) than did patients with similar-staged UC and fewer intratumoral CD8 TILs. We conclude that the extent of intratumoral CD8 TILs is an important prognostic indicator in advanced UC.

Overview

Integrity signals

Registry

Crossref · 10.1073/pnas.0611618104

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Research works printed but not linked: 8

  1. K Schumacher, W Haensch, C Roefzaad, PM Schlag Cancer Res 61, 3932–3936 (2001).
  2. Y Naito, K Saito, K Shiiba, A Ohuchi, K Saigenji, H Nagura, H Ohtani Cancer Res 58, 3491–3494 (1998).
  3. O Nakano, M Sato, Y Naito, K Suzuki, S Orikasa, M Aizawa, Y Suzuki, I Shintaku, H Nagura, H Ohtani Cancer Res 61, 5132–5136 (2001).
  4. YT Chen, LJ Old Cancer J Sci Am 5, 16–17 (1999).
  5. MJ Scanlan, AJ Simpson, LJ Old Cancer Immun 4, 1 (2004).
  6. E Jager, D Jager, A Knuth Onkologie 23, 410–415 (2000).
  7. T Nishiyama, M Tachibana, Y Horiguchi, K Nakamura, Y Ideda, K Takesako, M Murai Clin Cancer Res 7, 23–31 (2001).
  8. N Sadanaga, H Nagashima, K Mashino, K Tahara, H Yamaguchi, M Ohta, T Fujie, F Tanaka, H Inoue, K Takesako, T Akiyoshi, M Mori Clin Cancer Res 7, 2277–2784 (2001).

Cited by

See all 537

Metadata

Authors
Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., & Sato, E.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Tokyo Medical University (JP)
  • Ludwig Cancer Research (BE)
  • Memorial Sloan Kettering Cancer Center (US)
Venue
Proceedings of the National Academy of Sciences
Published
2007-03-06
Volume
104
Issue
10
Pages
3967-3972
ISSN
  • 0027-8424 (ISSN-L)
  • 1091-6490
OpenAlex
W2093773243
Cited by
526
References
29
Citations by year
2026: 13 · 2025: 11 · 2024: 25 · 2023: 38 · 2022: 51 · 2021: 54 · 2020: 40 · 2019: 40 · 2018: 32 · 2017: 35 · 2016: 34 · 2015: 32 · 2014: 25 · 2013: 16 · 2012: 15
FWCI
13.64
Type
journal article
Language
en
Open access
Locations
  • Proceedings of the National Academy of Sciences (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bladder and Urothelial Cancer Treatments
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
CD8+ T cells, tumor-infiltrating lymphocytes, muscle-invasive urothelial carcinoma, prognostic factors, MHC class I expression, NY-ESO-1, disease-free survival, overall survival, tumor immune microenvironment, tumor-associated antigens
MeSH terms
Antigens, Neoplasm, Urinary Bladder Neoplasms, Carcinoma, Female, Genes, MHC Class I, Humans, Immunohistochemistry, Male, Muscles, Prognosis, Lymphocytes, Tumor-Infiltrating, CD8 Antigens, Treatment Outcome, CD8-Positive T-Lymphocytes, Disease-Free Survival, Cell Line, Tumor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. https://app.cochat.ai/papers/10.1073/pnas.0611618104
The paper
Sharma, P., Shen, Y., Wen, S., Yamada, S., Jungbluth, A. A., Gnjatic, S., Bajorin, D. F., Reuter, V. E., Herr, H., Old, L. J., & Sato, E. (2007). CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.0611618104

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.